Allist(SH:688578) Xin Lang Cai Jing·2026-01-14 05:33Core Viewpoint - The stock price of Ailis has experienced fluctuations, with a recent decline of 1.47% year-to-date and a 5.33% drop over the last five trading days, indicating potential volatility in the market [2]. Group 1: Stock Performance - As of January 14, Ailis's stock price decreased by 2.07%, trading at 102.62 CNY per share, with a total market capitalization of 46.179 billion CNY [1]. - Year-to-date, Ailis's stock has dropped by 1.47%, while it has seen a 5.33% decline over the past five trading days [2]. - Over the last 20 days, the stock has increased by 1.48%, but it has decreased by 0.71% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Ailis reported a revenue of 3.733 billion CNY, reflecting a year-on-year growth of 47.35%, and a net profit attributable to shareholders of 1.616 billion CNY, which is a 52.01% increase [2]. - The company has distributed a total of 653 million CNY in dividends since its A-share listing [3]. Group 3: Shareholder and Institutional Holdings - As of September 30, 2025, Ailis had 19,100 shareholders, an increase of 46.82% from the previous period, with an average of 23,551 circulating shares per shareholder, down by 31.89% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 20.9471 million shares, an increase of 10.5693 million shares from the previous period [3]. - Other notable institutional shareholders include China Europe Medical Health Mixed A and E Fund Shanghai Stock Exchange Sci-Tech Innovation Board 50 ETF, with varying changes in their holdings [3].